M
Michael Jackson
Researcher at University of New South Wales
Publications - 105
Citations - 2933
Michael Jackson is an academic researcher from University of New South Wales. The author has contributed to research in topics: Medicine & Radiation therapy. The author has an hindex of 26, co-authored 91 publications receiving 2517 citations. Previous affiliations of Michael Jackson include University of Wollongong & Royal Prince Alfred Hospital.
Papers
More filters
Journal ArticleDOI
Biologically Targeted Magnetic Hyperthermia: Potential and Limitations.
David W. Chang,May Lim,Jeroen A.C.M. Goos,Jeroen A.C.M. Goos,Ruirui Qiao,Yun Yee Ng,Friederike M. Mansfeld,Friederike M. Mansfeld,Michael Jackson,Thomas P. Davis,Thomas P. Davis,Maria Kavallaris +11 more
TL;DR: There are numerous challenges that must be addressed before this technique can progress to the clinic and this review discusses these challenges and highlights the current understanding of targeted magnetic hyperthermia.
Journal ArticleDOI
Tirapazamine, Cisplatin, and Radiation Versus Fluorouracil, Cisplatin, and Radiation in Patients With Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)
Danny Rischin,Lester J. Peters,Richard I. Fisher,Andrew Macann,James W. Denham,Michael Poulsen,Michael Jackson,Lizbeth Kenny,Michael Penniment,June Corry,David Lamb,Bev McClure +11 more
TL;DR: Both chemoradiotherapy regimens are feasible and are associated with significant but acceptable toxicity profiles in the cooperative group setting and TPZ/CIS is being evaluated in a large phase III trial.
Journal ArticleDOI
Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
Christopher J. O'Brien,Edward McNeil,Jeremy D. McMahon,Irvin Pathak,Christopher S. Lauer,Michael Jackson +5 more
TL;DR: The aim of this study was to analyze the influence of clinical stage, extent of surgery, and pathologic findings on outcome after parotidectomy for metastatic SCC by applying a new staging system that separates metastatic disease in theParotid from metastatic Disease in the neck.
Journal ArticleDOI
Cancer Consultation Preparation Package: Changing Patients but Not Physicians Is Not Enough
Phyllis Butow,Rhonda J. Devine,Michael Boyer,Susan Pendlebury,Michael Jackson,Martin H.N. Tattersall +5 more
TL;DR: This CCPP influences patients' consultation behavior and does not increase anxiety in the long-term, however, this intervention, without physician endorsement, reduced the percentage of patients whose preferred involvement in decision making was achieved.
Journal ArticleDOI
N2‐N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders—Results of Trans Tasman Radiation Oncology Group Study 98.02
June Corry,Lester J. Peters,Lester J. Peters,Richard Fisher,Richard Fisher,Andrew Macann,Michael Jackson,Bev McClure,Danny Rischin,Danny Rischin +9 more
TL;DR: The aim of this study was to determine the incidence of isolated nodal failure in patients with N2/3 disease who achieved a complete clinical and radiological response at 12 weeks postchemoradiation, when no planned neck dissection was performed.